May, 2025
May 2025
M T W T F S S
 1234
567891011
12131415161718
19202122232425
262728293031  
David Sher: Dosimetric advantages of online adaptive radiation therapy for head and neck squamous cell carcinoma
Apr 21, 2025, 08:59

David Sher: Dosimetric advantages of online adaptive radiation therapy for head and neck squamous cell carcinoma

ASTRO shared a post on X:

“Dosimetric advantages of online adaptive radiation therapy for head and neck squamous cell carcinoma: results from a prospective registry study by David Sher, et al.

Read about it in the Red Journal.”

David Sher: Dosimetric advantages of online adaptive radiation therapy for head and neck squamous cell carcinoma

David SherMedical Director of Radiation Oncology, Chief of Head and Neck Radiation Oncology Service, reshared the post on X, adding:

In this paper, we analyzed the UTSW Radiation Oncology experience with adapt-on-demand for H&N squamous cell carcinoma using the Varian Ethos system.

TL/DR: Significant (and I think meaningful) improvement in coverage and homogeneity, but no clinically impactful reduction in OAR doses.”

Dosimetric advantages of online adaptive radiation therapy for head and neck squamous cell carcinoma: results from a prospective registry study.

Authors: Julia J. Shi, et al.

David Sher: Dosimetric advantages of online adaptive radiation therapy for head and neck squamous cell carcinoma